Bristol-Meyers Squibb Acquires Flexus Biosciences for $1,250,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f31d40a2-b490-450e-96b3-05064c045fd0
Date
2/23/2015
Company Name
Flexus Biosciences
Mailing Address
75 Shoreway Road San Carlos, CA 94070 USA
Company Description
Founded with the mission to create new cancer therapeutics through an innovative application of unexploited insights in immunology.
Website
http://www.flexusbio.com
Transaction Type
M&A
Transaction Amount
$1,250,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The transaction has a potential total consideration of $1.25 billion, including $800 million upfront and development milestones that, upon achievement, could total up to $450 million.